Skip to main content

Client News

Abivax 2024 Financial Communication Calendar

4th January 2024

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

4th January 2024

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide

29th December 2023

CARBIOS publishes its second sustainability report and confirms its ambitions to accelerate the circular economy for plastic

21st December 2023

invIOs to attend JP Morgan Week in San Francisco in January

21st December 2023

CARBIOS has received €1.2M of the €11.4M granted by ADEME to further optimize its unique PET depolymerization process and guarantee its competitiveness

20th December 2023

iOmx Therapeutics attends 2024 J.P. Morgan Healthcare Conference

20th December 2023

Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood

20th December 2023

Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site

20th December 2023

Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees

19th December 2023